SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-003133
Filing Date
2023-09-13
Accepted
2023-09-13 07:00:26
Documents
49
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2330164.htm   iXBRL 6-K 22781
2 EXHIBIT 99.1 exhibit_99-1.htm   iXBRL EX-99.1 983597
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 54782
  Complete submission text file 0001178913-23-003133.txt   4769864

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE evgn-20230630.xsd EX-101.SCH 68385
5 XBRL CALCULATION FILE evgn-20230630_cal.xml EX-101.CAL 48516
6 XBRL DEFINITION FILE evgn-20230630_def.xml EX-101.DEF 105695
7 XBRL LABEL FILE evgn-20230630_lab.xml EX-101.LAB 517742
8 XBRL PRESENTATION FILE evgn-20230630_pre.xml EX-101.PRE 227533
43 EXTRACTED XBRL INSTANCE DOCUMENT zk2330164_htm.xml XML 852915
Mailing Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121
Business Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121 97289311900
Evogene Ltd. (Filer) CIK: 0001574565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36187 | Film No.: 231251587
SIC: 2870 Agricultural Chemicals